Mainz Biomed B.V.
MYNZ | NASDAQ
$3.59
$0.00 (0.00%)
Nov 3, 2026, 9:40 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.41 | -0.19 | -28.64 | -151.87 | -248.86 | -7.98K |
PEG Ratio | 0 | 0 | 2.14 | -12.68 | -0.08 | 159.84 |
PS Ratio | 12.51 | 4.68 | 841.61 | 7.59K | 5.19K | 4.54K |
PB Ratio | 10.47 | 0.69 | 231.95 | 285.24 | 471.12 | -817.29 |
P/FCF Ratio | -0.61 | -0.24 | -31.62 | -260.61 | -925.80 | -4.68K |
P/OCF Ratio | -0.61 | -0.24 | -34.35 | -272.23 | -930.60 | -4.78K |
OCF/S Ratio | -2.04K | -1.91K | -2.45K | -2.79K | -557.78 | -94.97 |
Debt / Equity Ratio | 4.01 | 0.54 | 2.28 | 0.23 | 0.41 | -1.09 |
Quick Ratio | 0.44 | 1.26 | 0.91 | 4.29 | 7.11 | 0.27 |
Current Ratio | 0.50 | 1.32 | 0.97 | 4.33 | 7.11 | 0.27 |
Asset Turnover | 0.10 | 0.07 | 0.06 | 0.03 | 0.06 | 0.73 |
Interest Coverage | 36.15 | -17.39 | -32.91 | -91.40 | -28.67 | -2.85 |
Return on Equity | -2.53K% | -358.07% | -809.29% | -187.66% | -183.77% | 21.41% |
Return on Assets | -304.29% | -163.55% | -170.65% | -130.69% | -116.43% | -87.17% |
Return on Invested Capital | -420.12% | -192.86% | -233.79% | -152.64% | -108.81% | -321.96% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | -42.07% | 64.31% | 56.91% | 34.38% | 30.77% | 24.94% |
Net Profit Margin | -3.02K% | -2.42K% | -2.94K% | -4.99K% | -2.02K% | -118.91% |
Pretax Profit Margin | -3.02K% | -2.42K% | -2.94K% | -4.98K% | -2.03K% | -118.91% |
Operating Profit Margin | -2.51K% | -2.09K% | -2.98K% | -4.99K% | -1.68K% | -155.22% |
FCF Margin | -2.04K% | -1.94K% | -2.66K% | -2.91K% | -560.67% | -96.93% |
EBITDA Margin | -2.4K% | -2.19K% | -2.79K% | -4.85K% | -1.95K% | -52.20% |
Add to Watchlist
Select watchlists to add or remove MYNZ